Beyond Comprehensive Background Checks—The Potential Role of Firearm Purchaser Licensing
-
By
-
Stephen N. Oliphant
-
June 12, 2026
-
0 min
By
Stephen N. Oliphant
June 12, 2026
by Stephen N. Oliphant
June 12, 2026
by Chenxi Hu, Xun Li, Lu Yang, Ruolin Fang, Jinchang Huang, Ming Yang
June 12, 2026
Nearly 40% of registry patients would have been excluded from phase 3 randomized controlled trials, with exclusion criteria distributed unevenly across drug classes.
June 12, 2026